Mylan Q4 Profit Meets Estimate

(RTTNews) - Generic drug maker Mylan Inc. (MYL) reported net earnings for the fourth quarter of $189.2 million or $0.47 per share, compared to $180.2 million or $0.45 per share for the year-ago quarter.

Excluding items, adjusted net earnings for the fourth quarter was $419.8 million or $1.05 per share, compared to $308.1 million or $0.78 per share in the prior year quarter.

Total revenue for the fourth quarter rose 15% to $2.09 billion from $1.81 billion a year ago.

Analysts polled by Thomson Reuters expected the company to earn $1.05 per share on revenue of $2.07 billion for the fourth quarter. Analysts' estimates typically exclude special items.

Looking forward to 2015, the company forecasts total revenue of $9.6 billion to $10.1 billion and adjusted earnings of $4.00 to $4.30 per share. Analysts currently expect the company to earn $4.16 per share on revenue of $9.82 billion for the full year 2015.